FEBS Letters
Clinical and mechanistic insights into the roles of DDX41 in haematological malignancies
FEBS Letters, Volume 596, Issue 21, Page 2736-2745, November 2022.
FEBS Letters
Middle East respiratory syndrome coronavirus ORF4b protein inhibits TLR7‐ and TLR9‐dependent alpha interferon induction
FEBS Letters, Volume 596, Issue 19, Page 2538-2554, October 2022.
FEBS Letters
Maintenance of small molecule redox homeostasis in mitochondria
FEBS Letters, Volume 597, Issue 2, Page 205-223, January 2023.
FEBS Letters
E. coli cytochrome bd‐I requires Asp58 in the CydB subunit for catalytic activity
FEBS Letters, Volume 596, Issue 18, Page 2418-2424, September 2022.
FEBS Letters
A simplified and easy‐to‐use HIP HOP assay provides insights into chalcone antifungal mechanisms of action
FEBS Letters, Volume 596, Issue 23, Page 3087-3102, December 2022.
FEBS Letters
An excess of glycolytic enzymes under glucose‐limited conditions may enable Saccharomyces cerevisiae to adapt to nutrient availability
FEBS Letters, Volume 596, Issue 24, Page 3203-3210, December 2022.
FEBS Letters
The fusion of quantitative molecular proteomics and immune‐oncology: a step towards precision medicine in cancer therapeutics
FEBS Letters, Volume 596, Issue 21, Page 2721-2735, November 2022.
FEBS Letters
Novel insights into the regulation of cellular catabolic metabolism in macrophages through nuclear receptors
FEBS Letters, Volume 596, Issue 20, Page 2617-2629, October 2022.